Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 16, 2020 - Issue 1: Cannabis
792
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Cannabis and Epilepsy

& ORCID Icon
Pages 75-82 | Received 27 Feb 2019, Accepted 21 Jun 2019, Published online: 06 Aug 2019
 

Abstract

Objective: In recent years, the use of cannabidiol in the treatment of refractory epilepsy has been increasingly investigated and has been gaining public support as a novel way to treat these disorders. Marijuana has been used for medical purposes for thousands of years, and a lot of research has been conducted over the last several decades into the chemistry and pharmacology of marijuana and its many compounds, including cannabidiol. Methods: Using PubMed, we performed a review of the literature regarding the history of cannabinoid use in treating epilepsy. Results and conclusions: There are historical and recent scientific developments that support the use of cannabidiol in rare severe epilepsy syndromes.

Acknowledgments

The authors of this article would like to thank the Epilepsy division at the UT Southwestern Medical Center as well as the Department of Neurology and Neurotherapeutics.

Disclosure statement

The authors have no disclosures.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.